- Home
- ADBE vs BMY Comparison
ADBE vs BMY Comparison
Compare ADBE & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADBE | BMY |
|---|---|---|
| Founded | 1982 | 1887 |
| Country | United States | United States |
| Employees | N/A | 32500 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.2B | 123.7B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADBE | BMY |
|---|---|---|
| Price | $282.38 | $60.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 15 |
| Target Price | ★ $402.95 | $61.93 |
| AVG Volume (30 Days) | 5.0M | ★ 11.2M |
| Earning Date | 03-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.15% |
| EPS Growth | ★ 35.11 | N/A |
| EPS | ★ 16.70 | N/A |
| Revenue | ★ $23,769,000,000.00 | N/A |
| Revenue This Year | $11.70 | N/A |
| Revenue Next Year | $9.11 | N/A |
| P/E Ratio | ★ $16.93 | $17.26 |
| Revenue Growth | ★ 10.53 | N/A |
| 52 Week Low | $244.28 | $42.52 |
| 52 Week High | $444.35 | $63.33 |
Technical Indicators
Market Signals| Indicator | ADBE | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 56.69 | 52.06 |
| Support Level | $247.69 | $59.23 |
| Resistance Level | $364.32 | $62.05 |
| Average True Range (ATR) | 8.96 | 1.20 |
| MACD | 4.99 | -0.27 |
| Stochastic Oscillator | 93.11 | 25.02 |
Price Performance
Historical ComparisonAbout ADBE Adobe Inc.
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.